Océanie · Marchés régionaux · Stockhead

Recce topical gel shows strong diabetic foot infection efficacy ahead of Phase III data review

Publié par Stockhead · Australie il y a 6 h

A review of blinded data from Recce’s Phase III trial of its RECCE 327 Gel in diabetic foot infections has ... Read More The post Recce topical gel shows strong diabetic foot…

Lire l'article complet sur Stockhead Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (stockhead.com.au)

Recce topical gel shows strong diabetic foot infection efficacy ahead of Phase III data review

À lire aussi

Landholders and politicians push for tougher laws on renewable energy developments

FROM THE HILL: A snapshot of today's politics and parliament

Here are the top 10 ASX 200 shares today

Bellroy reveals plans for 20 stores as Australian accessories brand goes global with physical retail

Welcome to peak chaos

Escrow plans for existing investors sank Firmus float: report

Recce topical gel shows strong diabetic foot infection efficacy ahead of Phase III data review

Partager

À lire aussi

Landholders and politicians push for tougher laws on renewable energy developments

FROM THE HILL: A snapshot of today's politics and parliament

Here are the top 10 ASX 200 shares today

Bellroy reveals plans for 20 stores as Australian accessories brand goes global with physical retail

Welcome to peak chaos

Escrow plans for existing investors sank Firmus float: report